Skip to Main Content
Contribute Try STAT+ Today

A bill moving through the Washington legislature may make the state only the second in the U.S. with hopes of distributing its own line of generic drugs, an idea hatched last year in California as a way to combat the rising cost of prescription medicines that are straining government budgets.

The legislation would authorize the state Health Care Authority to form partnerships with other state agencies or nonprofits to distribute generics and insulin. However, any drug must be made or distributed by a pharmaceutical company that is registered with the Food and Drug Administration.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.